Publication Name	World Journal of Gastroenterology
Manuscript ID	72456
Country	Türkiye

Received	2021-10-22 04:41
Peer-Review Started	2021-10-22 04:43
To Make the First Decision
Return for Revision	2021-12-01 05:04
Revised	2021-12-11 08:55
Second Decision	2022-01-13 01:01
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-01-13 01:43
Articles in Press	2022-01-13 01:43
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-01-13 09:17
Publish the Manuscript Online	2022-01-22 06:41

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Letter to the Editor
Article Title	Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer?
Manuscript Source	Invited Manuscript
All Author List	Semra Demirli Atici and Erdinc Kamer
ORCID	Author(s) ORCID Number Semra Demirli Atici http://orcid.org/0000-0002-8287-067X Erdinc Kamer http://orcid.org/0000-0002-5084-5867
Funding Agency and Grant Number
Corresponding Author	Semra Demirli Atici, MD, Surgeon, Department of General Surgery, University of Health Sciences Tepecik Training and Research Hospital, Güney Mahallesi, 1140/1 Sokak No:1 Yenişehir/Konak, İzmir 35180, Türkiye. smrdemirli@hotmail.com
Key Words	Colorectal cancer; Carbohydrate antigen 19-9; Liver metastasis of colorectal cancer; Synchronous liver metastasis; Chemotherapy; Metastatic colorectal cancer
Core Tip	It is important to evaluate synchronous liver metastases of colorectal cancer (CRC) and to determine the response to chemotherapy in patients. Based on findings from such, the optimal treatment method is selected for each patient. The scoring system described in the study, created through a combination of radiology and laboratory parameters, can guide treatment. However, we think that it would be more appropriate to discuss the results of this study in the context of other studies conducted with patients with stage IV CRC.
Publish Date	2022-01-22 06:41
Citation	Demirli Atici S, Kamer E. Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer? World J Gastroenterol 2022; 28(4): 500-501
URL	https://www.wjgnet.com/1007-9327/full/v28/i4/500.htm
DOI	https://dx.doi.org/10.3748/wjg.v28.i4.500

Full Article (PDF)	WJG-28-500.pdf
Full Article (Word)	WJG-28-500.docx
Manuscript File	72456_Auto_Edited.docx
Answering Reviewers	72456-Answering reviewers.pdf
Audio Core Tip	72456-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	72456-Conflict-of-interest statement.pdf
Copyright License Agreement	72456-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	72456-Language certificate.pdf
Peer-review Report	72456-Peer-review(s).pdf
Scientific Misconduct Check	72456-CrossCheck.png
Scientific Misconduct Check	72456-Bing-Gong ZM-2.png
Scientific Editor Work List	72456-Scientific editor work list.pdf